ALLO $0.84 +1.41%

ALLO · Allogene Therapeutics, Inc.

Track ALLO — free

$0.84 +0.01 (+1.41%) At close · Nov 13 Play latest call Q2 2026 earnings call transcript

Russell 2000 member Rebalance outlook locked

Market Cap

$290.58M

Shares

346.47M

Volume · Nov 13 11.66M Avg daily vol (3M) 7.37M

Earnings call · FY2019 Q4

Allogene Therapeutics, Inc. (ALLO) Q4 2019 Earnings Call

Concluded Feb 27, 2020

Feb 27, 2020

Period: FY2019 Q4
Runtime: —
Sources: 2 artifacts

Net income -$61.03M

Open full screen 8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Feb 27, 2020 10-K report Filed Feb 27, 2020

Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →